<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248546</url>
  </required_header>
  <id_info>
    <org_study_id>2010/144 (REK)</org_study_id>
    <nct_id>NCT01248546</nct_id>
  </id_info>
  <brief_title>Tomosynthesis in the Oslo Breast Cancer Screening Program</brief_title>
  <acronym>DBT</acronym>
  <official_title>Digital Breast Tomosynthesis in the Oslo Mammography Screening Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cancer Registry of Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hologic, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Digital Breast Tomosynthesis (DBT) in the Oslo Mammography Screening Program will include&#xD;
      women aged 50 to 69 years invited to the population-based mammography-screening program. All&#xD;
      women attending the screening unit will be asked if they want to attend the trial. If so,&#xD;
      they will be informed about the project, the technique, and the additional compression and&#xD;
      radiation dose. All mammographic examinations of women attending the trial will be&#xD;
      independently interpreted by four radiologists. Since the trial is part of the official&#xD;
      Norwegian Breast Cancer Screening Program (NBCSP), the interpretations will be carried out&#xD;
      on-line into the national screening database of the NBCSP. The study will include independent&#xD;
      reading of conventional digital (2D) mammograms, 2D plus computer-aided detection (CAD), 2D&#xD;
      plus DBT, and synthetic 2D plus DBT. There will be a common consensus meeting for all&#xD;
      examinations having a positive score. Recalls and diagnostic work-up will be according to&#xD;
      daily practice at the Oslo University Hospital Ullevaal and the guidelines of the NBCSP.&#xD;
&#xD;
      Outcome measures will use performance indicators for organized screening programs, including&#xD;
      recall rate, false positive scores, cancer detection rate, positive predictive values, and&#xD;
      cancer characteristics for the individual readers of the trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Screening performance indicators</measure>
    <time_frame>From Nov. 22, 2010 to Dec. 31, 2012</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interval cancer rate</measure>
    <time_frame>From Nov. 23, 2010 to Dec. 31, 2014</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25000</enrollment>
  <condition>Recall Rate</condition>
  <condition>Cancer Detection Rate</condition>
  <condition>False Positive Rate</condition>
  <condition>Positive Predictive Value</condition>
  <arm_group>
    <arm_group_label>Digital mammography</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Digital breast tomosynthesis</intervention_name>
    <description>The participants included in the trial will have an additional radiation exposure for breast tomosynthesis</description>
    <arm_group_label>Digital mammography</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women aged 50 to 69 years attending the national breast cancer screening program who sign&#xD;
        an informed consent regarding participation in the trial&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women 50 to 69 years who have signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women with pacemaker, implants, and severely disabled&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oslo University Hospital, Ulleval</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>February 4, 2013</last_update_submitted>
  <last_update_submitted_qc>February 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Per Skaane</investigator_full_name>
    <investigator_title>professor dr. med.</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Computer-aided detection</keyword>
  <keyword>Mammography screening</keyword>
  <keyword>Digital breast tomosynthesis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

